{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:50:39Z","timestamp":1793573439391,"version":"4.5.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>We present a patient with Rabson-Mendenhall syndrome with unsatisfactory glycemic control of diabetes despite the use of metformin, pioglitazone, and sitagliptin. We investigated the long-term effects of treatment with an empagliflozin. After one year of empagliflozin therapy, an improvement in metabolic control of diabetes was detected. However, eleven months after implementation of empagliflozin, the patient was diagnosed with an early form of nephrocalcinosis. The empagliflozin dose was reduced, maintaining metabolic control and reducing hypercalciuria. We discuss the probable causes of nephrocalcinosis as well as the potential impact of SGLT-2 inhibitor therapy on the occurrence and progression of renal calcium deposition.<\/jats:p>","DOI":"10.3389\/fendo.2025.1552690","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T04:10:22Z","timestamp":1743567022000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case Report: The long-term effects of the empagliflozin therapy on glycemia and renal function in a patient with Rabson-Mendenhall syndrome caused by two heterozygous variants in INSR gene"],"prefix":"10.3389","volume":"16","author":[{"given":"Joanna","family":"Chrzanowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lachowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Weimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Zubkiewicz-Kucharska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstancja","family":"Fornalczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Kilis-Pstrusi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Smigiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"B1","first-page":"1993","article-title":"INSR-Related Severe Insulin Resistance Syndrome","volume-title":"GeneReviews","author":"Mesika","year":"2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000366225","article-title":"Insulin receptor and the kidney: nephrocalcinosis in patients with recessive INSR mutations","volume":"128","author":"Simpkin","year":"2014","journal-title":"Nephron Physiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-013-0490-x","article-title":"Six cases with severe insulin resistance (SIR) associated with mutations of insulin receptor: Is a Bartter-like syndrome a feature of congenital SIR","volume":"50","author":"Grasso","year":"2013","journal-title":"Acta Diabetol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051268","article-title":"Mecasermin in insulin receptor-related severe insulin resistance syndromes: case report and review of the literature","volume":"19","author":"Plamper","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1159\/000519613","article-title":"Use of a sodium-glucose cotransporter 2 inhibitor, empagliflozin, in a patient with rabson-mendenhall syndrome","volume":"94","author":"Dos Santos","year":"2021","journal-title":"Horm Res Paediatr"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-055671","article-title":"SGLT2i improves glycemic control in patients with congenital severe insulin resistance","volume":"150","author":"Galderisi","year":"2022","journal-title":"Pediatrics"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1414451","article-title":"Case report: A case of Rabson-Mendenhall syndrome: long-term follow-up and therapeutic management with empagliflozin","volume":"15","author":"Foglino","year":"2024","journal-title":"Front Genet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/cge.14516","article-title":"Genebe.net: Implementation and validation of an automatic ACMG variant pathogenicity criteria assignment","volume":"106","author":"Stawi\u0144ski","year":"2024","journal-title":"Clin Genet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1978.tb02218.x","article-title":"The hypercalciuria of diabetes mellitus: its amelioration with insulin","volume":"9","author":"Raskin","year":"1978","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B11","article-title":"Rabson-mendenhall syndrome","volume":"59","author":"Kumar","year":"2005","journal-title":"Indian J Med Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12483","article-title":"Gastrointestinal dysmotility and pancreatic insufficiency in 2 siblings with Donohue syndrome","volume":"18","author":"Kostopoulou","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.61917","article-title":"Ultra-rapid emergency genomic diagnosis of Donahue syndrome in a preterm infant within 17\u2009hours","volume":"185","author":"Bamborschke","year":"2021","journal-title":"Am J Med Genet A"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00519","article-title":"Insulin: trigger and target of renal functions","volume":"8","author":"Pina","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2010060681","article-title":"Activation of PI3-kinase stimulates endocytosis of ROMK via Akt1\/SGK1-dependent phosphorylation of WNK1","volume":"22","author":"Cheng","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-014-0606-y","article-title":"Bartter-like syndrome in patients with molecular defects of the insulin receptor gene","volume":"51","author":"Watanabe","year":"2014","journal-title":"Acta Diabetol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.04010609","article-title":"Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target","volume":"5","author":"Santer","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/mnh.0000000000000505","article-title":"Effects of sodium glucose cotransporter 2 inhibitors on mineral metabolism in type 2 diabetes mellitus","volume":"28","author":"Vinke","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1879-5","article-title":"Multidrug therapy in a patient with Rabson-Mendenhall syndrome","volume":"53","author":"Moreira","year":"2010","journal-title":"Diabetologia"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1552690\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T04:10:37Z","timestamp":1743567037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1552690\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":19,"alternative-id":["10.3389\/fendo.2025.1552690"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1552690","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"article-number":"1552690"}}